Although diabetic nephropathy is caused by a different pathomechanism affecting primarily glomerular capillaries, it is clear from large trials that renal outcome is improved when treating patients with ACE inhibitors [26, 27]. The gene discussed is ACE; the disease is diabetic kidney disease.